Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.

Paige E, Barrett J, Pennells L, Sweeting M, Willeit P, Di Angelantonio E, Gudnason V, Nordestgaard BG, Psaty BM, Goldbourt U, Best LG, Assmann G, Salonen JT, Nietert PJ, Verschuren WMM, Brunner EJ, Kronmal RA, Salomaa V, Bakker SJL, Dagenais GR, Sato S, Jansson JH, Willeit J, Onat A, de la Cámara AG, Roussel R, Völzke H, Dankner R, Tipping RW, Meade TW, Donfrancesco C, Kuller LH, Peters A, Gallacher J, Kromhout D, Iso H, Knuiman M, Casiglia E, Kavousi M, Palmieri L, Sundström J, Davis BR, Njølstad I, Couper D, Danesh J, Thompson SG, Wood A.

Am J Epidemiol. 2017 Oct 15;186(8):899-907. doi: 10.1093/aje/kwx149.

2.

Association of Cardiometabolic Multimorbidity With Mortality.

Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O'Keeffe LM, Gao P, Wood AM, Burgess S, Freitag DF, Pennells L, Peters SA, Hart CL, Håheim LL, Gillum RF, Nordestgaard BG, Psaty BM, Yeap BB, Knuiman MW, Nietert PJ, Kauhanen J, Salonen JT, Kuller LH, Simons LA, van der Schouw YT, Barrett-Connor E, Selmer R, Crespo CJ, Rodriguez B, Verschuren WM, Salomaa V, Svärdsudd K, van der Harst P, Björkelund C, Wilhelmsen L, Wallace RB, Brenner H, Amouyel P, Barr EL, Iso H, Onat A, Trevisan M, D'Agostino RB Sr, Cooper C, Kavousi M, Welin L, Roussel R, Hu FB, Sato S, Davidson KW, Howard BV, Leening MJ, Rosengren A, Dörr M, Deeg DJ, Kiechl S, Stehouwer CD, Nissinen A, Giampaoli S, Donfrancesco C, Kromhout D, Price JF, Peters A, Meade TW, Casiglia E, Lawlor DA, Gallacher J, Nagel D, Franco OH, Assmann G, Dagenais GR, Jukema JW, Sundström J, Woodward M, Brunner EJ, Khaw KT, Wareham NJ, Whitsel EA, Njølstad I, Hedblad B, Wassertheil-Smoller S, Engström G, Rosamond WD, Selvin E, Sattar N, Thompson SG, Danesh J.

JAMA. 2015 Jul 7;314(1):52-60. doi: 10.1001/jama.2015.7008. Erratum in: JAMA. 2015 Sep 15;314(11):1179. Leening, Maarten [corrected to Leening, Maarten J G].

3.

Peak flow rate and death due to coronary heart disease: 30-year results from the Northwick Park Heart cohort study.

Clayton TC, Meade TW, Turner EL, De Stavola BL.

Open Heart. 2014 Oct 8;1(1):e000164. doi: 10.1136/openhrt-2014-000164. eCollection 2014.

4.

C-reactive protein, fibrinogen, and cardiovascular disease prediction.

Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J.

N Engl J Med. 2012 Oct 4;367(14):1310-20. doi: 10.1056/NEJMoa1107477.

5.

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z.

Lancet. 2012 Apr 28;379(9826):1591-601. doi: 10.1016/S0140-6736(12)60209-8. Epub 2012 Mar 21.

PMID:
22440947
6.

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z, Meade TW.

Lancet. 2012 Apr 28;379(9826):1602-12. doi: 10.1016/S0140-6736(11)61720-0. Epub 2012 Mar 21. Review.

PMID:
22440946
7.

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.

IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, Gao P, Saleheen D, Rendon A, Nelson CP, Braund PS, Hall AS, Chasman DI, Tybjærg-Hansen A, Chambers JC, Benjamin EJ, Franks PW, Clarke R, Wilde AA, Trip MD, Steri M, Witteman JC, Qi L, van der Schoot CE, de Faire U, Erdmann J, Stringham HM, Koenig W, Rader DJ, Melzer D, Reich D, Psaty BM, Kleber ME, Panagiotakos DB, Willeit J, Wennberg P, Woodward M, Adamovic S, Rimm EB, Meade TW, Gillum RF, Shaffer JA, Hofman A, Onat A, Sundström J, Wassertheil-Smoller S, Mellström D, Gallacher J, Cushman M, Tracy RP, Kauhanen J, Karlsson M, Salonen JT, Wilhelmsen L, Amouyel P, Cantin B, Best LG, Ben-Shlomo Y, Manson JE, Davey-Smith G, de Bakker PI, O'Donnell CJ, Wilson JF, Wilson AG, Assimes TL, Jansson JO, Ohlsson C, Tivesten Å, Ljunggren Ö, Reilly MP, Hamsten A, Ingelsson E, Cambien F, Hung J, Thomas GN, Boehnke M, Schunkert H, Asselbergs FW, Kastelein JJ, Gudnason V, Salomaa V, Harris TB, Kooner JS, Allin KH, Nordestgaard BG, Hopewell JC, Goodall AH, Ridker PM, Hólm H, Watkins H, Ouwehand WH, Samani NJ, Kaptoge S, Di Angelantonio E, Harari O, Danesh J.

Lancet. 2012 Mar 31;379(9822):1205-13. doi: 10.1016/S0140-6736(11)61931-4. Epub 2012 Mar 14.

8.

The Northwick Park Heart Studies: contrasts between the two factor VII assays used.

Meade TW, Stirling Y.

J Thromb Haemost. 2012 Mar;10(3):482-4. doi: 10.1111/j.1538-7836.2012.04616.x. No abstract available.

9.

Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database.

Clayton TC, Gaskin M, Meade TW.

Int J Epidemiol. 2011 Jun;40(3):819-27. doi: 10.1093/ije/dyr012. Epub 2011 Feb 15.

10.

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW.

Lancet. 2011 Jan 1;377(9759):31-41. doi: 10.1016/S0140-6736(10)62110-1. Epub 2010 Dec 6.

PMID:
21144578
11.

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW.

Lancet. 2010 Nov 20;376(9754):1741-50. doi: 10.1016/S0140-6736(10)61543-7. Epub 2010 Oct 21.

PMID:
20970847
12.

Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts.

dos Santos Silva I, De Stavola BL, Pizzi C, Meade TW.

Int J Epidemiol. 2010 Jun;39(3):699-709. doi: 10.1093/ije/dyq012. Epub 2010 Mar 24.

PMID:
20338892
13.

Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.

Rudnicka AR, MacCallum PK, Whitelocke R, Meade TW.

Eye (Lond). 2010 Jul;24(7):1199-206. doi: 10.1038/eye.2010.8. Epub 2010 Feb 12.

PMID:
20150922
14.

Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).

Pizzi C, De Stavola BL, Meade TW.

Int J Epidemiol. 2010 Feb;39(1):256-65. doi: 10.1093/ije/dyp245. Epub 2009 Jul 13.

PMID:
19596751
15.

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

Fibrinogen Studies Collaboration, Jackson D, White I, Kostis JB, Wilson AC, Folsom AR, Wu K, Chambless L, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Levy D, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen J, Nyyssönen K, Tuomainen TP, Hedblad B, Engström G, Berglund G, Loewel H, Koenig W, Hense HW, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Lowe GD, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Brennan P, Knottenbelt C, Cooper JA, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Lowe GD, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Di Angelantonio E, Kaptoge S, Lewington S, Lowe GD, Sarwar N, Thompson SG, Walker M, Watson S, White IR, Wood AM, Danesh J.

Stat Med. 2009 Apr 15;28(8):1218-37. doi: 10.1002/sim.3540.

16.

Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.

Bartlett JW, De Stavola BL, Meade TW.

J Thromb Haemost. 2009 Feb;7(2):270-6. doi: 10.1111/j.1538-7836.2008.03236.x. Epub 2008 Nov 22.

17.

Health related quality of life after combined hormone replacement therapy: randomised controlled trial.

Welton AJ, Vickers MR, Kim J, Ford D, Lawton BA, MacLennan AH, Meredith SK, Martin J, Meade TW; WISDOM team.

BMJ. 2008 Aug 21;337:a1190. doi: 10.1136/bmj.a1190.

18.

The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, Guyatt GH, Mark DB, Harrington RA.

Chest. 2008 Jun;133(6 Suppl):776S-814S. doi: 10.1378/chest.08-0685.

PMID:
18574278
19.

Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database.

Clayton TC, Thompson M, Meade TW.

Eur Heart J. 2008 Jan;29(1):96-103. Epub 2007 Dec 6.

PMID:
18063596
20.

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

Emerging Risk Factors Collaboration, Danesh J, Erqou S, Walker M, Thompson SG, Tipping R, Ford C, Pressel S, Walldius G, Jungner I, Folsom AR, Chambless LE, Knuiman M, Whincup PH, Wannamethee SG, Morris RW, Willeit J, Kiechl S, Santer P, Mayr A, Wald N, Ebrahim S, Lawlor DA, Yarnell JW, Gallacher J, Casiglia E, Tikhonoff V, Nietert PJ, Sutherland SE, Bachman DL, Keil JE, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, Giampaoli S, Palmieri L, Panico S, Vanuzzo D, Pilotto L, Simons L, McCallum J, Friedlander Y, Fowkes FG, Lee AJ, Smith FB, Taylor J, Guralnik J, Phillips C, Wallace R, Blazer D, Khaw KT, Jansson JH, Donfrancesco C, Salomaa V, Harald K, Jousilahti P, Vartiainen E, Woodward M, D'Agostino RB, Wolf PA, Vasan RS, Pencina MJ, Bladbjerg EM, Jorgensen T, Moller L, Jespersen J, Dankner R, Chetrit A, Lubin F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Bjorkelund C, Cremer P, Nagel D, Tilvis R, Strandberg T, Rodriguez B, Bouter LM, Heine RJ, Dekker JM, Nijpels G, Stehouwer CD, Rimm E, Pai J, Sato S, Iso H, Kitamura A, Noda H, Goldbourt U, Salomaa V, Salonen JT, Nyyssönen K, Tuomainen TP, Deeg D, Poppelaars JL, Meade T, Cooper J, Hedblad B, Berglund G, Engstrom G, Döring A, Koenig W, Meisinger C, Mraz W, Kuller L, Selmer R, Tverdal A, Nystad W, Gillum R, Mussolino M, Hankinson S, Manson J, De Stavola B, Knottenbelt C, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Naito Y, Holme I, Nakagawa H, Miura H, Ducimetiere P, Jouven X, Crespo C, Garcia-Palmieri M, Amouyel P, Arveiler D, Evans A, Ferrieres J, Schulte H, Assmann G, Shepherd J, Packard C, Sattar N, Cantin B, Lamarche B, Després JP, Dagenais GR, Barrett-Connor E, Wingard D, Bettencourt R, Gudnason V, Aspelund T, Sigurdsson G, Thorsson B, Trevisan M, Witteman J, Kardys I, Breteler M, Hofman A, Tunstall-Pedoe H, Tavendale R, Lowe GD, Ben-Shlomo Y, Howard BV, Zhang Y, Best L, Umans J, Onat A, Meade TW, Njolstad I, Mathiesen E, Lochen ML, Wilsgaard T, Gaziano JM, Stampfer M, Ridker P, Ulmer H, Diem G, Concin H, Rodeghiero F, Tosetto A, Brunner E, Shipley M, Buring J, Cobbe SM, Ford I, Robertson M, He Y, Ibanez AM, Feskens EJ, Kromhout D, Collins R, Di Angelantonio E, Kaptoge S, Lewington S, Orfei L, Pennells L, Perry P, Ray K, Sarwar N, Scherman M, Thompson A, Watson S, Wensley F, White IR, Wood AM.

Eur J Epidemiol. 2007;22(12):839-69. Epub 2007 Sep 18.

PMID:
17876711
21.

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW; WISDOM group.

BMJ. 2007 Aug 4;335(7613):239. Epub 2007 Jul 11.

22.

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.

Vickers MR, Martin J, Meade TW; WISDOM study team.

BMC Womens Health. 2007 Feb 26;7:2.

25.

Commentary: fibrinogen and coronary heart disease--test of causality by 'Mendelian' randomization by Keavney et al.

Meade TW, Humphries SE, De Stavola BL.

Int J Epidemiol. 2006 Aug;35(4):944-7. Epub 2006 Jul 26. No abstract available.

PMID:
16870676
26.

Recent respiratory infection and the risk of myocardial infarction.

Clayton TC, Capps NE, Stephens NG, Wedzicha JA, Meade TW.

Heart. 2005 Dec;91(12):1601-2. No abstract available.

27.

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A.

JAMA. 2005 Oct 12;294(14):1799-809. Erratum in: JAMA. 2005 Dec 14;294(22):2848.

PMID:
16219884
28.

Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes.

Meade TW.

J Thromb Haemost. 2005 Apr;3(4):632-4. No abstract available.

29.

Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction.

MacCallum PK, Rudnicka AR, Rumley A, Meade TW, Lowe GD.

Br J Haematol. 2004 Nov;127(4):448-50.

PMID:
15521923
30.

Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Harrington RA, Becker RC, Ezekowitz M, Meade TW, O'Connor CM, Vorchheimer DA, Guyatt GH.

Chest. 2004 Sep;126(3 Suppl):513S-548S. Review.

PMID:
15383483
31.

Effect of bezafibrate on plasma homocysteine concentration in men with lower extremity arterial disease.

MacCallum PK, Cooper JA, Rumley A, Lowe GD, Meade TW.

J Thromb Haemost. 2004 Feb;2(2):364-5. No abstract available.

32.

Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

Jamshidi Y, Flavell DM, Hawe E, MacCallum PK, Meade TW, Humphries SE.

Atherosclerosis. 2002 Jul;163(1):183-92.

PMID:
12048138
33.

Thrombosis prevention trial: follow-up study of practical implications.

Fasey N, Brennan PJ, Meade TW; MRC General Practice Research Framework. Medical Research Council.

Br J Gen Pract. 2002 Mar;52(476):208-9.

34.

Antithrombotic treatment and the incidence of angina pectoris.

Knottenbelt C, Brennan PJ, Meade TW; Medical Research Council's General Practice Research Framework.

Arch Intern Med. 2002 Apr 22;162(8):881-6.

PMID:
11966338
35.

HERS and its aftermath.

Meade TW.

Climacteric. 1999 Mar;2(1):2-5. No abstract available.

PMID:
11910675
36.

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421].

Meade TW; For the British Medical Research Council General Practice Research Framework and participating vascular clinics .

Curr Control Trials Cardiovasc Med. 2001 Jul 23;2(4):195-204.

37.

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.

Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA.

Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23.

PMID:
11719299
38.

Cardiovascular disease--linking pathology and epidemiology.

Meade TW.

Int J Epidemiol. 2001 Oct;30(5):1179-83.

PMID:
11689542
39.

Psychological characteristics and fatal ischaemic heart disease.

Haines A, Cooper J, Meade TW.

Heart. 2001 Apr;85(4):385-9.

40.

Authors' reply on aspirin for primary prevention.

Meade TW, Brennan PJ.

BMJ. 2001 Jan 20;322(7279):171. No abstract available.

41.

Antithrombotic agents in coronary artery disease.

Cairns JA, Théroux P, Lewis HD Jr, Ezekowitz M, Meade TW.

Chest. 2001 Jan;119(1 Suppl):228S-252S. Review. No abstract available. Erratum in: Chest 2001 Oct;120(4):1427.

PMID:
11157652
42.

A prospective study of faecal bile acids and colorectal cancer.

Haines A, Hill MJ, Thompson MH, Owen RW, Williams RE, Meade TW, Wilkes H, Griffin M.

Eur J Cancer Prev. 2000 Oct;9(5):317-23.

PMID:
11075884
43.

Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease.

MacCallum PK, Brennan PJ, Meade TW.

Arch Intern Med. 2000 Sep 11;160(16):2462-8.

PMID:
10979057
44.

Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.

Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, Jeffries DJ, Meade TW.

Thromb Haemost. 2000 Aug;84(2):210-5.

PMID:
10959691
46.

Haemostatic function, arterial disease and the prevention of arterial thrombosis.

MacCallum PK, Meade TW.

Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):577-99. Review.

PMID:
10856986
48.

Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.

MacCallum PK, Cooper JA, Martin J, Howarth DJ, Meade TW, Miller GJ.

Thromb Haemost. 2000 Mar;83(3):421-6.

PMID:
10744148
49.

HRT and cardiovascular disease.

Meade TW, Vickers MR.

J Epidemiol Biostat. 1999;4(3):165-90. Review.

PMID:
10695958
50.

Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease.

Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD.

Circulation. 2000 Dec 5;102(23):2816-22.

PMID:
11104738

Supplemental Content

Loading ...
Support Center